BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bellon A, Nguyen K. Selective serotonin reuptake inhibitors and risk reduction for cardiovascular disease in patients with schizophrenia: A controversial but promising approach. World J Psychiatr 2021; 11(7): 316-324 [PMID: 34327124 DOI: 10.5498/wjp.v11.i7.316]
URL: https://www.wjgnet.com/2220-3206/full/v11/i7/316.htm
Number Citing Articles
Catherine W. Bennett, Lauren Gensler, David R. Goldsmith. Antipsychotics and Medical Comorbidity: A Retrospective Study in an Urban Outpatient Psychiatry ClinicCommunity Mental Health Journal 2023; 59(4): 641 doi: 10.1007/s10597-022-01045-2
Daria A. Kamaeva, Daria V. Kazantseva, Anastasiia S. Boiko, Irina A. Mednova, Liudmila P. Smirnova, Elena G. Kornetova, Svetlana A. Ivanova. The Influence of Antipsychotic Treatment on the Activity of Abzymes Targeting Myelin and Levels of Inflammation Markers in Patients with SchizophreniaBiomedicines 2023; 11(4): 1179 doi: 10.3390/biomedicines11041179
Faiez Iqbal, Aneemaa Narayan, Mallicka Chatrath, Mohammad Iqbal. Examining the Association Between Serotonergic Antidepressants and Blood Transfusion Requirements in Orthopaedic Surgery: A Comprehensive AnalysisCureus 2023;  doi: 10.7759/cureus.45988
O. Godin, B. Pignon, A. Szoke, L. Boyer, B. Aouizerate, B. Schorr, M. André, D. Capdevielle, I. Chereau, N. Coulon, R. Dassing, C. Dubertret, B. Etain, S. Leignier, P.M. Llorca, J. Mallet, D. Misdrahi, C. Passerieux, R. Rey, M. Urbach, F. Schürhoff, M. Leboyer, G. Fond. 3-year incidence and predictors of metabolic syndrome in schizophrenia in the national FACE-SZ cohortProgress in Neuro-Psychopharmacology and Biological Psychiatry 2023; 120: 110641 doi: 10.1016/j.pnpbp.2022.110641
Joseph Dao, Savreen Saran, Melody Wang, Christina Michael, Nhu-y Phan, Alfredo Bellon. A Systematic Review on the Potential of Aspirin to Reduce Cardiovascular Risk in SchizophreniaBrain Sciences 2023; 13(2): 368 doi: 10.3390/brainsci13020368
Hélène Verdoux, Clélia Quiles, Jose de Leon. Optimizing antidepressant and clozapine co-prescription in clinical practice: A systematic review and expert recommendationsSchizophrenia Research 2023;  doi: 10.1016/j.schres.2023.10.003